Copyright
©The Author(s) 2022.
World J Transplant. Jun 18, 2022; 12(6): 131-141
Published online Jun 18, 2022. doi: 10.5500/wjt.v12.i6.131
Published online Jun 18, 2022. doi: 10.5500/wjt.v12.i6.131
Figure 1 PRISMA flow diagram.
1Three articles included in the systematic review reported cases of extraneural metastases from both oligodendrogliomas and astrocytomas.
Figure 2 Survival analysis of patients with extra-central nervous system metastases of oligodendroglioma and astrocytoma.
CNS: Central nervous system; Mtx: Metastasis.
Figure 3 Time from initial diagnosis to metastatic spread in patients with and without intra-central nervous system recurr ences/metastases.
A: Oligodendrogliomas; B: Astrocytomas. CNS: Central nervous system; Mtx: Metastasis.
- Citation: Ammendola S, Barresi V, Bariani E, Girolami I, D’Errico A, Brunelli M, Cardillo M, Lombardini L, Carraro A, Boggi U, Cain O, Neil D, Eccher A. Risk factors of extraneural spreading in astrocytomas and oligodendrogliomas in donors with gliomas: A systematic review. World J Transplant 2022; 12(6): 131-141
- URL: https://www.wjgnet.com/2220-3230/full/v12/i6/131.htm
- DOI: https://dx.doi.org/10.5500/wjt.v12.i6.131